This report presents findings related to the hepatitis B and C continuum of care, policy on testing and treatment, and the impact of the COVID-19 pandemic on hepatitis services in the EU/EEA from the second data collection conducted in 2021.
ECDC provides support to EU/EEA countries in monitoring their progress towards the hepatitis elimination targets and has just published a report based on the second data collection.
The Management Board approves and monitors implementation of ECDC’s work programme and budget, it adopts its annual report and accounts - all in all, it acts as the governing body of the Centre.
The purpose of this policy is to lay down the rules for reimbursement of expenses that have been incurred by invitees who were invited by ECDC (the Centre) to a meeting/event/activity or similar.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5-11 June 2022 and includes updates on West Nile virus infection, COVID-19, hepatitis, monkeypox, measles and MERS-CoV.